Back to library

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Amylin Analog · Metabolic

Pramlintide (Symlin)

Amylin analog adjunct to mealtime insulin.

FDA-Approved

Plain-Language Label Highlights

Brand names: Symlin

What it's approved for

Type 1 and type 2 diabetes (with mealtime insulin) when sugar isn't controlled by insulin alone.

A mealtime injection that works with insulin to slow digestion, reduce after-meal blood sugar, and curb appetite.

Boxed Warning

Severe insulin-induced low blood sugar — reduce mealtime insulin by 50% when starting.

Common side effects
  • Nausea
  • Decreased appetite
  • Vomiting
  • Headache
  • Stomach pain
Serious risks to know
  • Severe hypoglycemia (especially with insulin)
  • Allergic reactions
Who should avoid or use with extra caution
  • Hypoglycemia unawareness
  • Confirmed gastroparesis
  • Poor compliance with insulin/glucose monitoring

Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.

Mechanism of Action

Synthetic analog of the pancreatic hormone amylin. Slows gastric emptying, suppresses inappropriate postprandial glucagon, and increases satiety as adjunct to insulin.

Research Areas

Type 1 diabetes (with insulin)
Type 2 diabetes on insulin

Common Research Protocols

Mealtime

15–120 mcg SC before major meals (titrated).

Protocols summarized for educational reference from published research. Not dosing guidance.

Cited Research

[1]Diabetes Care·2003

Pramlintide in T1D

Improved A1c and reduced postprandial glucose excursions.

Important Considerations

  • FDA-approved.
  • Boxed warning: severe insulin-induced hypoglycemia.

Explore more peptides

Educational Information Only — Not Medical Advice

All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.

Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.

Searching the library…

Ask the Library

Ask anything about peptides — answers come from our curated reference library with citations.

Find a pharmacy that carries Pramlintide (Symlin)

Leave your details and a vetted partner pharmacy will reach out with availability and pricing.